`
`IPR2015-00229
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`_________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________________
`
`SONY COMPUTER ENTERTAINMENT AMERICA LLC
`Petitioner
`
`v.
`
`APLIX IP HOLDINGS CORPORATION
`Patent Owner
`
`________________________
`
`Case No. IPR2015-00229
`Patent No. 7,667,692
`
`____________________
`
`
`
`PATENT OWNER APLIX IP HOLDINGS CORPORATION’S
`MOTION FOR OBSERVATION ON DECEMBER 17, 2015
`DEPOSITION OF GREGORY F. WELCH
`
`
`1
`
`
`
`
`
`
`
`
`
`U.S. Patent No. 7,667,692
`
`IPR2015-00229
`
`
`
`Pursuant to 77 Fed. Reg. 48756, 48768 (Aug. 14, 2012), Patent Owner Aplix
`
`IP Holdings Corporation submits the following observations on the December 17,
`
`2015 deposition of Gregory Welch (exhibit 2022).
`
`1.
`
`In Exhibit 2022 (’245/’692 Welch 12-17-15 deposition), on page 6,
`
`line 10 through page 10, line 25, Dr. Welch testified about his supplemental
`
`declaration’s response to various points raised by Dr. Karon MacLean, an expert
`
`whose testimony Aplix has submitted, including Dr. Welch’s understanding that
`
`Dr. MacLean’s opinion was that application-level software “must redefine spatial
`
`boundaries of the delineated active areas” (page 6, line 24, through page 7, line 4)
`
`(quoting ’245 Welch supplemental declaration, ¶ 7) and that in her view there is a
`
`“requirement that the spatial boundaries of the delineated active areas themselves
`
`must change from application to application” (page 10, line 4-14) (quoting ’245
`
`Welch supplemental declaration, ¶ 8). (The supplemental paragraph numbers 7
`
`and 8 are substantively the same in the ’692 Welch supplemental declaration as in
`
`the ’245 Welch supplemental declaration.) This testimony is relevant to the
`
`testimony of Dr. MacLean that in her view the delineated active areas had to be
`
`“changeable” (exhibit 2003, ¶¶ 66, 72), not that they necessarily had to change
`
`(exhibit 1040, ’245/’692 MacLean deposition, page 67, line 23 to page 68, line 4).
`
`The testimony is relevant because it shows that Dr. Welch’s critique of
`
`Dr. MacLean’s opinion is based on a misunderstanding of that opinion.
`
`
`
`2
`
`
`
`U.S. Patent No. 7,667,692
`
`IPR2015-00229
`
`
`
`2.
`
`In Exhibit 2022 (’245/’692 Welch 12-17-15 deposition), on page 11,
`
`line 1, through page 15, line 11, Dr. Welch testified that he could not identify
`
`anything in the ’245/’692 specification explicitly saying that the active areas are
`
`defined by system-level (as opposed to application-level) software. This testimony
`
`is relevant to Dr. MacLean’s opinion that, for example, Liebenow does not meet
`
`the ’692 patent’s claim 3 phrase “based on the selected application” because
`
`Liebenow “does not disclose ‘providing’ delineations as delineations are not
`
`defined by or based on the application” at ¶ 66 of exhibit 2003 (’692 MacLean
`
`declaration). The testimony is relevant because it supports Dr. MacLean’s opinion.
`
`3.
`
`In Exhibit 2022 (’245/’692 Welch 12-17-15 deposition), on page 15,
`
`line 13, through page 17, line 5, Dr. Welch testified about the ’245/’692
`
`specification’s inclusion of at least one example showing application-level
`
`configuration, as opposed to system-level configuration, of active areas. This
`
`testimony is relevant to Dr. MacLean’s opinion mentioned above (in paragraph 2).
`
`The testimony is relevant for the same reason—because it supports Dr. MacLean’s
`
`opinion.
`
`4.
`
`In Exhibit 2022 (’245/’692 Welch 12-17-15 deposition), on page 25,
`
`line 13, through page 28, line 18, Dr. Welch testified that three sections of the
`
`Liebenow specification discuss embodiments of Liebenow’s invention, but the
`
`“Background of the Invention” section, which includes a reference to PDAs, does
`
`
`
`3
`
`
`
`U.S. Patent No. 7,667,692
`
`IPR2015-00229
`
`
`not. This testimony is relevant to Dr. Welch’s testimony suggesting that
`
`Liebenow’s device could be a PDA in exhibit 1041 (’692 Welch supplemental
`
`declaration), ¶ 13. The testimony is relevant because it shows that the example on
`
`which Dr. Welch relies is not taken from the description of Liebenow’s invention.
`
`
`
`4
`
`
`
`U.S. Patent No. 7,667,692
`
`IPR2015-00229
`
`By: ___/Sybil L. Dunlop/________________________
` Robert J. Gilbertson (pro hac vice)
`Sybil L. Dunlop (pro hac vice)
`X. Kevin Zhao (pro hac vice)
`GREENE ESPEL PLLP
`222 South Ninth Street, Suite 2200
`Minneapolis, MN 55402
`Telephone: (612) 373-0830
`Facsimile:
`(612) 373-0929
`E-mail: BGilbertson@GreeneEspel.com
` SDunlop@GreeneEspel.com
` KZhao@GreeneEspel.com
`
`Michael Mauriel, USPTO Reg. No. 44,226
`Sherman W. Kahn (pro hac vice)
` MAURIEL KAPOUYTIAN WOODS LLP
`15 West 26th Street, Floor 7
`New York, NY 10010
`Telephone: (212) 529-5131
`Facsimile:
`(212) 529-5132
`E-mail:
`mmauriel@mkwllp.com
` skahn@mkwllp.com
`
` Attorneys for Patent Owner
` Aplix IP Holdings Corporation
`
`
`
`
`5
`
`
`Dated: December 23, 2015.
`
`
`
`
`
`
`
`
`
`U.S. Patent No. 7,667,692
`
`IPR2015-00229
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 23rd day of
`December 2015, the foregoing Patent Owner Aplix IP Holdings Corporation’s
`Motion for Observation is being served via email on the following counsel of
`record for petitioner.
`
`
`Lead Counsel
`Eric A. Buresh (Reg. No. 50,394)
`Eric.buresh@eriseip.com
`
`Postal and Hand-Delivery Address:
`ERISE IP, P.A.
`6201 College Blvd., Suite 300
`Overland Park, Kansas 66211
`Telephone: (913) 777-5600
`Fax: (913) 777-5601
`
`Back-Up Counsel
`Abran J. Kean (Reg. No. 58,540)
`Abran.kean@eriseip.com
`
`Postal and Hand-Delivery Address:
`ERISE IP, P.A.
`5600 Greenwood Plaza Blvd., Suite
`200
`Greenwood Village, Colorado 80111
`Telephone: (913) 777-5600
`Fax: (913) 777-5601
`
`_____/Sybil L. Dunlop/_________________________
`Robert J. Gilbertson (pro hac vice)
`Sybil L. Dunlop (pro hac vice)
`X. Kevin Zhao (pro hac vice)
`GREENE ESPEL PLLP
`222 South Ninth Street, Suite 2200
`Minneapolis, MN 55402
`Telephone: (612) 373-0830
`Facsimile: (612) 373-0929
`
`
`Counsel for Patent Owner Aplix IP Holdings
`Corporation
`
`
`
`
`Dated: December 23, 2015.
`
`
`
`6